PMDA drug package insert
ゼプリオンTRI水懸筋注175mgシリンジ
PMDA Prescription drug · ヤンセンファーマ株式会社 · package insert Dec 25, 2025
Key facts
| Brand names | ゼプリオンTRI水懸筋注175mgシリンジ, ゼプリオンTRI水懸筋注263mgシリンジ, ゼプリオンTRI水懸筋注350mgシリンジ, ゼプリオンTRI水懸筋注525mgシリンジ |
|---|---|
| Nonproprietary names | パリペリドンパルミチン酸エステル |
| Companies | 製造販売元（輸入）／ヤンセンファーマ株式会社, 発売元／住友ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持効性抗精神病剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179409G6027, 1179409G7023, 1179409G8020, 1179409G9026 |
| Approval numbers | 30200AMX00931000, 30200AMX00932000, 30200AMX00933000, 30200AMX00934000 |
| Package insert edition | 第6版 |
| Package insert date | Dec 25, 2025 |
| PMDA document key | 800155_1179409G6027_1 |
| PMDA company code | 800155 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: